1. Academic Validation
  2. Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action

Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action

  • Bioorg Med Chem. 2012 Sep 15;20(18):5537-49. doi: 10.1016/j.bmc.2012.07.043.
Ramiro Vázquez 1 María E Riveiro Mónica Vermeulen Eliana Alonso Carolina Mondillo Graciela Facorro Lidia Piehl Natalia Gómez Albertina Moglioni Natalia Fernández Alberto Baldi Carina Shayo Carlos Davio
Affiliations

Affiliation

  • 1 Laboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental (IBYME)-CONICET, Vuelta de Obligado 2490 (C1428ADN), Buenos Aires, Argentina; Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica-UBA, Junín 954 (C1113AAD), Buenos Aires, Argentina. ramirobioq@hotmail.com
Abstract

Previous studies indicated the need of at least one phenolic hydroxyl group in the coumarin core for induction of cytotoxicity in different cell lines. Herein, we present an exhaustive structure-activity relationship study including ortho-dihydroxycoumarins (o-DHC) derivatives, cinnamic acid derivatives (as open-chain coumarin analogues) and 1,2-pyrones (representative of the δ-lactone ring of the coumarin core), carried out to further identify the structural features of o-DHC required to induce leukemic cell differentiation and Apoptosis in U-937 cells. Our results show for the first time that the δ-lactone ring positively influences the aforementioned biological effects, by conferring greater potency to compounds with an intact coumarin nucleus. Most tellingly, we reveal herein the crucial role of this molecular portion in determining the selective toxicity that o-DHC show for leukemic cells over normal blood cells. From a pharmacological perspective, our findings point out that o-DHC may be useful prototypes for the development of novel chemotherapeutic agents.

Figures
Products